Dopaminergic regulation of pre-proNPY mRNA levels in the rat arcuate nucleus
Related Experiment Video
Updated: Sep 30, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
1MRC Group in Molecular Endocrinology, Laval University Medical Center, Québec, Que. Canada.
Abstract:
In order to study the role of dopamine on neuropeptide Y (NPY) gene expression in the rat arcuate nucleus, we evaluated the effects of haloperidol, a dopaminergic antagonist, and bromocriptine, a D2 dopamine receptor agonist, on the levels of pre-proNPY mRNA as measured by in situ hybridization. Chronic treatment with bromocriptine produced a moderate decrease of the hybridization signal, whereas haloperidol treatment resulted in a marked increase in signal intensities. These results indicate that, in the arcuate nucleus, NPY neurons are negatively regulated by dopaminergic-mediated mechanisms acting most likely through D2 receptors.
Insights
Dopamine signaling negatively regulates neuropeptide Y (NPY) gene expression in the rat arcuate nucleus, likely via D2 receptors. Dopaminergic antagonists increased NPY mRNA, while agonists decreased it.
Area of Science:
- Neuroscience
- Endocrinology
- Molecular Biology
Background:
- Neuropeptide Y (NPY) plays a crucial role in regulating energy balance and appetite.
- Dopamine is a key neurotransmitter implicated in various physiological processes, including feeding behavior.
- The arcuate nucleus is a critical brain region for integrating metabolic and hormonal signals to control energy homeostasis.
Purpose of the Study:
- To investigate the influence of dopamine on neuropeptide Y (NPY) gene expression within the rat arcuate nucleus.
- To elucidate the specific dopamine receptor subtypes involved in this regulation.
Main Methods:
- Utilized in situ hybridization to quantify pre-proNPY mRNA levels in rat arcuate nucleus.
- Administered haloperidol (a dopaminergic antagonist) and bromocriptine (a D2 dopamine receptor agonist) chronically.
- Assessed changes in NPY gene expression following pharmacological interventions.
Main Results:
- Chronic bromocriptine treatment led to a moderate reduction in the NPY mRNA hybridization signal.
- Haloperidol treatment resulted in a significant increase in NPY mRNA signal intensity.
- These findings suggest a direct impact of dopaminergic activity on NPY neurons.
Conclusions:
- Dopaminergic mechanisms exert a negative regulatory control over NPY gene expression in the arcuate nucleus.
- This regulation is likely mediated through D2 dopamine receptors.
- The study provides insights into the neurochemical control of appetite and energy balance.
Related Concept Videos
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
RNA Editing
Regulation of Expression at Multiple Steps
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Regulation of Food Intake

